Durability Marketing Company

From IT-Core
Revision as of 04:13, 11 September 2026 by MontyMacleod2 (talk | contribs)
Jump to navigation Jump to search


Meta Facebook ads for wellness for Longevity, Peptide Therapy & IV Therapy Clinics. A center that releases a durability Meta program expecting med-spa business economics or TRT-style patient quantity burns spending plan and ends incorrectly that "Meta does not benefit longevity." Meta jobs; the program simply needs to value what's in fact difficult about the category.

We report on enrolled method people (earnings), material engagement deepness (leading indicator), and FDA-status compliance insurance coverage (risk-management metric). Audience-building has to count much more greatly on lookalikes from existing patients (HIPAA-carefully sourced) and on interest-adjacency from closely-associated podcasters and brands.

The audience is biohacker-educated, reflexively ad-skeptical, and convinced most long life marketing is serpent oil. Biohacker audiences have actually been educated to discount sleek health and wellness ads. Counterintuitively, a phone-shot 8-minute provider explainer regularly outperforms a $20k studio-produced innovative place on this audience.

This style matches how the audience already eats health web content. They're the earliest signal that the innovative is landing with the right target market. We integrate Meta imaginative with podcast-placement initiatives (clips of your supplier on podcasts your audience already pays attention to, retargeted to podcast-listener lookalikes).

The TRT Meta policies (taking on nationwide brand names, symptom-adjacent innovative) do not use due to the fact that there are no leading nationwide longevity brands running Meta advertisements-- the network is actually under-saturated. We develop 90-180 day retargeting home windows with innovative rotation-- different supplier, different modality, different angle every 3-4 weeks-- so the audience sees 10-15 substantive touches before the speak with CTA ever terminates.